Invitae
NVTA
$0.01950
Share price
0.00%
Change (1 day)
-98.61%
Change (1 year)
P/S ratio for Invitae (NVTA)
P/S ratio as of May 2024 (TTM): 0.0116
According to Invitae 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.0116005. At the end of 2023 the company had a P/S ratio of 0.3510.
P/S ratio history for Invitae from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.3510 | -59.89% |
| 2022 | 0.8750 | -88.34% |
| 2021 | 7.51 | -71.59% |
| 2020 | 26.4 | 259.51% |
| 2019 | 7.35 | 30.03% |
| 2018 | 5.65 | -19.79% |
| 2017 | 7.05 | -31.48% |
| 2016 | 10.3 | -67.13% |
| 2015 | 31.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Celldex Therapeutics CLDX | 358 | 3,088,801.34% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | 0.1669 | 1,339.14% | 🇺🇸 USA |
 CareDx CDNA | 1.43 | 12,255.93% | 🇺🇸 USA |